Parenteral artesunate access programme aims at reducing malaria fatality rates in South Africa

South African Medical Journal

Volumn 101, Issue 4, 2011, Pages 240-241

  Visser Kift, E ^a   Kredo, T ^b   Barnes, K I ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ARTESUNATE;

ABSENCE OF SIDE EFFECTS; ARTICLE; COMORBIDITY; DISEASE SEVERITY; DRUG EFFICACY; DRUG QUALITY; DRUG SAFETY; FATALITY; HUMAN; MALARIA; MALARIA FALCIPARUM; MORBIDITY; MORTALITY; PATIENT COMPLIANCE; PLASMODIUM FALCIPARUM; QUALITY CONTROL; SOUTH AFRICA; TREATMENT OUTCOME;

EID: 79955940110     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: 10.7196/samj.4761     Document Type: Article

References (7)

1. Day N, Dondorp AM. The management of patients with severe malaria. Am J Trop Med Hyg 2007;77(6):29-35.
2. World Health Organization Guidelines for the Treatment of Malaria, 2nd ed. Geneva: World Health Organization, 2006. http://whqlibdoc.who.int/publications/2010/9789241547925_eng.pdf (accessed 29 December 2010).
3. South East Asian Quinine Artesunate Malaria Trial (SEAQUAMAT) group. Artesunate versus quinine for treatment of severe falciparum malaria: a randomized trial. Lancet 2005;366:717-725.
4. Jones KL, Donegan S, Lalloo DG. Artesunate versus quinine for treating severe malaria. Cochrane Database of Systematic Reviews 2007, Issue 4. Art. No.: CD005967. DOI:10.1002/14651858.CD005967. pub2. (review update 2010, Issue 1.)
5. Feachem RGA, Malaria Elimination Group. Shrinking the Malaria Map: A Guide on Malaria Elimination for Policy Makers. http://www.malariaeliminationgroup.org/sites/default/files/fileuploads/AGuideonMalariaEliminationforPolicyMakers.pdf (accessed 29 December 2010).
6. Weber IB, Baker L, Mnyaluza J, et al. The burden of imported malaria in Gauteng Province. S Afr Med J 2010;100:300-303.
7. Dondorp AM, Fanello CI, Hendriksen ICE, et al. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomized trial. Lancet 2010;376:1647-1657.